Lantheus Holdings, Inc. Other Non-Current Liabilities
Lantheus Holdings, Inc. (LNTH) had Other Non-Current Liabilities of $91.53 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $91.53M.
- 2026-03-31: Other Liabilities, Noncurrent $105.23M.
- 2025-12-31: Other Liabilities, Noncurrent $107.87M.
- 2025-09-30: Other Liabilities, Noncurrent $116.18M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $91.53M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $105.23M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $107.87M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $116.18M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $102.18M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $58.19M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $63.18M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $61.99M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $63.54M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $63.11M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $63.32M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $62.85M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $49.07M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $46.21M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $46.16M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $46.49M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $49.62M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $58.78M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $124.89M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $89.64M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $91.79M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $64.86M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $63.39M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $65.38M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $64.16M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $29.04M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $28.40M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $42.72M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $43.70M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $42.74M 10-Q · filed 2019-04-30 | |
| 2018-12-31 | $40.79M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $39.32M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $38.48M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $37.85M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $38.01M 10-K · filed 2019-02-20 | |
| 2017-09-30 | $37.18M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $36.17M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $35.63M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $34.74M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $33.72M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $34.05M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $34.24M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $34.14M 10-K · filed 2017-02-23 | $33.95M 10-K · filed 2016-03-02 |
| 2015-09-30 | $33.52M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $32.80M 10-Q · filed 2015-08-05 | |
| 2014-12-31 | $33.60M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |